Squamous cell carcinoma of the head and neck

Journal of B.U.ON.

Volumn 7, Issue 4, 2002, Pages 311-317

  Vermorken, Jan B ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; DNA TOPOISOMERASE INHIBITOR; DOCETAXEL; FLUDARABINE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; MITOMYCIN C; NUCLEOSIDE ANALOG; PACLITAXEL; PLATINUM; TAXANE DERIVATIVE;

ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COUGHING; DERMATITIS; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; DRUG POTENTIATION; DRUG TOXICITY; DYSPNEA; EAR DISEASE; FEBRILE NEUTROPENIA; HEAD AND NECK CARCINOMA; HIGH RISK PATIENT; HUMAN; KIDNEY DISEASE; LUNG METASTASIS; LYMPH NODE; METASTASIS; MOUTH CAVITY; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NEUROLOGIC DISEASE; NEUTROPENIA; POSTOPERATIVE PERIOD; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; TREATMENT OUTCOME; VOMITING;

EID: 0037650141     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Shah JP, Cendon RA, Farr HW, Strong EW. Carcinoma of the oral cavity. Factors affecting treatment failure at the primary site and neck. Am J Surg 1976; 132: 504-507.
2. Johnson JT, Myers EN, Bedetti CD et al. Cervical lymph node metastases. Incidence and implications of extracapsular carcinoma. Arch Otolaryngol 1985; 111: 534-537.
3. Snow GB, Balm AJM, Arendsen JW et al. Prognostic factors in neck node metastasis. In: Larson DL, Ballantyne AJ, Guillamondequi OM (eds): Cancer in the Neck. New York: Macmillan, 1986: pp 53-63.
4. Vermorken JB. Adjuvant chemotherapy for advanced squamous cell carcinoma of the head and neck. In: Snow GB, Clark JR (eds): Multimodality Therapy for Head and Neck Cancer. New York: Georg Thieme Verlag, 1992: pp 112-126.
5. Al-Sarraf M, Hussein M. Head and neck cancer: Present status and future prospects of adjuvant chemotherapy. Cancer Investig 1995; 13: 41-53.
6. Steel GG, Peckham MJ. Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity. Int J Radiat Oncol Biol Phys 1979; 5: 85-91.
7. Stell PM, Rawson NS. Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990; 61: 779-787.
8. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995; 71: 83-91.
9. El Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 1996; 14: 838-847.
10. Browman GP, Hodson DI, Mackenzie RJ et al. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer. A systemic review of the published literature with subgroup analysis. Head Neck 2001; 23: 579-589.
11. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck cancer squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000; 355: 949-955.
12. Ang KK, Trotti A, Brown BW et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 571-578.
13. Awwad HK, Lotayef M, Shouman T et al. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: Influence of proliferation. Br J Cancer 2002; 86: 517-523.
14. Laramore GE, Scott CB, Al-Sarraf M et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on intergroup study 0034. Int J Radiat Oncol Biol Phys 1992; 23: 705-713.
15. Adelstein DJ. Recent randomized studies of chemoradiation in the management of locally advanced head and neck cancer. Curr Opin Oncol 1998; 10: 213-218.
16. Adelstein DJ. Oropharynx cancer: The role of the medical oncologist in organ-function conservation. ASCO Educational Book 1999, pp 544-550.
17. Brizel DM. Management of advanced head and neck cancer with radiotherapy and concurrent chemotherapy: Improvements in efficacy and toxicity management strategies. ASCO Educational Book 2000, pp 219-225.
18. Bachaud JM, Cohen JE, Alzieu C et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial. Int J Radiat Oncol Biol Phys 1996; 36: 999-1004.
19. Haffty BG, Son YH, Papac R et al. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale mitomycin randomized trials. J Clin Oncol 1997; 15: 268-276.
20. Bernier J, Domenge C, Eschwege F. Chemo-radiotherapy, as compared to radiotherapy alone, significantly increases disease-free and overall survival in head and neck cancer patients after surgery: Results of EORTC phase III trial 22931. Int J Radiat Oncol Biol Phys 2001; 51 (Suppl 1): 1 (abstr).
21. Cooper JS, Pajak TF, Forastiere AA et al. Postoperative concurrent radiochemotherapy in high-risk SCCA of the head and neck: Initial report of RTOG 9501/intergroup phase III trial. Proc Am Soc Clin Oncol 2002; 21: 225a (abstr).
22. Busto G, Corvo R, Ricci I et al. New chemoradiotherapy combinations in head and neck cancer. Expert Rev Anticancer Ther 2001; 1: 111-115.
23. Feher O, Valadares AD, Nicolau UR et al. Paclitaxel and cisplatin concurrent with radiotherapy for larynx preservation in advanced resectable laryngeal and hypopharyngeal squamous cell carcinomas: Preliminary results of a phase II study. Proc Am Soc Clin Oncol 2002; 21: 240a (abstr).
24. Domenge C, Marandas P, Vignoud J et al. Post-surgical adjuvant chemotherapy in extracapsular spread invaded lymph node (N+R+) of epidermoid carcinoma of the head and neck. A randomized mutlicentric trial. Second Intern Conf Head Neck Cancer, Boston, 1988. Am Soc Head Neck Surg 1988; 74 (abstr).
25. Tsukuda M, Ogasawara H, Kaneko S et al. A prospective randomized trial of adjuvant chemotherapy with UFT for head and neck carcinoma. Head and Neck UFT study group. Gan To Kagaku Ryoho 1994; 21: 1169.
26. Adjuvant chemotherapy for advanced head and neck squamous carcinoma: Final report of the Head and Neck Contract Program. Cancer 1987; 60: 301-311.
27. Ervin TJ, Clark JR, Weichselbaum RR et al. An analysis of induction and adjuvant chemotherapy in multidisciplinary treatment of squamous cell carcinoma of the head and neck. J Clin Oncol 1987; 5: 10-20.
28. Marks SC, Lolachi CM, Shamsa F et al. Outcome of pyriform sinus cancer: A retrospective institutional review. Laryngoscope 1996; 106: 27-31.
29. Sarini J, Bocciolini C, Fournier C et al. Induction chemotherapy and larynx preservation: Is such practice useful? Bull Cancer 2002; 89: 411-417.
30. Leon X, Quer M, Orus C, Prado Venegas M. Can cure be achieved in patients with head and neck carcinomas? The problem of second neoplasm. Expert Rev Anticancer Ther 2001; 1: 125-133.
31. Kowalski LP, Carvalho AL. Natural history of untreated head and neck cancer. Eur J Cancer 2000; 36: 1032-1037.
32. Schantz SP, Harrison LB, Forastiere AA. Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx. In: DeVita CT, Hellman S, Rosenberg SA (eds). Cancer: Principles & Practice of Oncology, Lippincott-Raven Publishers, Philadelphia (6th edn), 2001, pp 797-860.
33. Al-Sarraf M. Head and neck cancer: Chemotherapy concepts. Semin Oncol 1988; 15: 70-85.
34. Urba SG, Forastiere AA. Systemic therapy of head and neck cancer: Most effective agents, areas of promise. Oncology 1989; 3: 79-88.
35. Forastiere AA, Metch B, Schuller DE et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 1992; 10: 1245-1251.
36. Schrijvers D, Vermorken JB. Role of taxoids in head and neck cancer. The Oncologist 2000; 5: 199-208.
37. Kim KB, Khuri FR, Shin DM. Recent advances in the management of squamous cell carcinoma of the head and neck. Exper Rev Anticancer Ther 2001; 1: 99-110.
38. Murphy B, Li Y, Cella D et al. Phase III study comparing cisplatin & 5-fluorouracil versus cisplatin and paclitaxel in metastatic/recurrent head & neck cancer. Proc Am Soc Clin Oncol 2001; 20: 224a (abstr #894).